This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Edinburgh Imaging | |
|---|---|
| Name | Edinburgh Imaging |
| Type | Research infrastructure |
| Location | Edinburgh, Scotland |
| Parent organizations | University of Edinburgh, NHS Lothian |
| Established | 2008 |
| Focus | Medical imaging, biomedical research, translational imaging |
Edinburgh Imaging is a multidisciplinary imaging research infrastructure based in Edinburgh, Scotland, supporting biomedical and clinical imaging across academic, clinical, and industrial partners. It provides centralized access to imaging equipment, technical expertise, and governance frameworks that link the University of Edinburgh with NHS Lothian, collaborating units such as the MRC Centre for Regenerative Medicine, the Roslin Institute, and the Centre for Clinical Brain Sciences. The facility underpins research connected to major initiatives including the UK Biobank imaging protocols, the Wellcome Trust funding ecosystem, the EPSRC networks, and translational pipelines tied to the Medical Research Council.
Edinburgh Imaging was founded to consolidate imaging capabilities dispersed across the University of Edinburgh and NHS Lothian hospitals, emerging amid investments from bodies like the Wellcome Trust, the Scottish Funding Council, and the European Research Council. Its development paralleled the expansion of campus resources such as the Queen's Medical Research Institute and the refurbishment of facilities adjacent to the Royal Infirmary of Edinburgh and the Western General Hospital. Historical milestones include installation of high-field magnetic resonance systems coordinated with projects funded by the NIHR and strategic partnerships with technology vendors linked to the Science and Technology Facilities Council.
Governance combines academic, clinical, and commercial oversight through committees representing the University of Edinburgh, NHS Lothian, and research councils such as the Medical Research Council and the British Heart Foundation. Operational leadership interfaces include directors drawn from the Usher Institute, the Centre for Neuroimaging Sciences, and principal investigators affiliated with the Institute for Regeneration and Repair. Ethical review and data governance coordinate with the Edinburgh Clinical Trials Unit, the NHS Research Ethics Service, and institutional boards aligned to standards endorsed by the Human Tissue Authority and the Health Research Authority.
The infrastructure hosts a spectrum of modalities spanning preclinical and clinical platforms: high-field and ultra-high-field Magnetic Resonance Imaging scanners, computed tomography systems with links to the Royal Hospital for Sick Children, hybrid positron emission tomography–magnetic resonance units reflecting collaborations with Siemens Healthineers and GE Healthcare, and optical imaging suites used alongside the Centre for Regenerative Medicine. Facilities include dedicated cyclotron-linked radiochemistry labs coordinating with the Wolfson Molecular Imaging Centre model and histology cores integrated with the Roslin Institute. Support services encompass image processing clusters interoperable with the EPCC computing resources and data management aligned to the UK Research and Innovation data policies.
Research programs traverse neuroimaging, cardiovascular imaging, oncology imaging, and musculoskeletal imaging, with investigators connected to the Centre for Clinical Brain Sciences, the BHF Centre of Research Excellence, and the Cancer Research UK Edinburgh Centre. Collaborative projects include multicentre trials with partners at Imperial College London, University College London, King's College London, and international nodes such as the Max Planck Society and the Karolinska Institutet. Funding and consortium links extend to the European Molecular Biology Laboratory, the NIHR Clinical Research Network, and biomedical engineering groups within the Royal Academy of Engineering outreach.
Clinical translation emphasizes stroke imaging, neurodegenerative disease biomarkers, cardiac function assessment, and image-guided oncology interventions used in pathways interacting with the Royal Infirmary of Edinburgh stroke services, the NHS Scotland cancer networks, and specialty clinics at the Western General Hospital. Trials supported by the infrastructure align with regulatory frameworks from the Medicines and Healthcare products Regulatory Agency and outcome measures that feed into national audits such as those by the Scottish Stroke Improvement Programme and registries associated with the National Cancer Research Institute.
Training programs serve postgraduate researchers, clinical radiographers, and visiting fellows through modules co-delivered by the Edinburgh Medical School, the Centre for Cognitive and Neural Systems, and the Roslin Institute. Short courses and accredited workshops address advanced magnetic resonance techniques, PET radiochemistry, quantitative image analysis, and research data management, leveraging pedagogic links to the UK Bioinformatics Coordination Initiative and professional bodies such as the Royal College of Radiologists.
Notable achievements include contributions to large-scale cohort imaging protocols akin to the UK Biobank imaging pipeline, methodological advances in multimodal neuroimaging adopted by consortia such as the Human Connectome Project, and deployment of novel MR sequences later standardized in collaborations involving the International Society for Magnetic Resonance in Medicine. The centre has supported high-impact clinical trials with partners including the NIHR and industry collaborators such as GlaxoSmithKline and AstraZeneca, and has produced translational outputs informing practice within the NHS Lothian network.
Category:Medical imaging in Scotland Category:University of Edinburgh research